Topical use of mitomycin C for the treatment of corneal-conjunctival intraepithelial neoplasia and conjunctival squamous cell carcinoma: preliminary results

Related authors

• Priscilla Luppi Ballalai
• José Álvaro Pereira Gomes
• Myrna Serapião dos Santos
• Denise de Freitas
• Clélia Maria Erwenne
• Moacyr Rigueiro

Related articles

• Frequency of conjunctival epithelial dysplasia in patients with pterygium
• Novel low-cost approach to the treatment of ocular surface squamous neoplasia using pattern scanning laser photocoagulation
• Anterior lamellar corneoscleral keratoplasty for the management of corneal thinning following treatment with mitomycin-C and interferon to treat highly suspected ocular surface squamous neoplasia: a case report
• Masquerade syndrome in ocular surface squamous neoplasia
• Primary basal cell carcinoma of the caruncle: case report and review of the literature
• The regression time of ocular surface squamous neoplasia using topical interferon alfa-2b does not depend on the initial tumor size
• Chronic unilateral tearing as a sign of lacrimal sac squamous cell carcinoma
• Metastatic and aggressive renal cell carcinoma mimicking a unilateral choroidal tuberculoma
• Analysis of ocular surface and quality of life in patients with corneal and conjunctival tumors
• Optimizing the effective doses of mitomycin C, 5-fluorouracil, and their combination on cultivated basal cell carcinoma

Click here to search